Total Payments
$210,097
2024 Payments
$12,000
Companies
50
Transactions
1,242
Medicare Patients
4,131
Medicare Billing
$613,319
Payment Breakdown by Category
Other$103,861 (49.4%)
Food & Beverage$58,954 (28.1%)
Travel$28,571 (13.6%)
Consulting$18,695 (8.9%)
Education$15.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,585 | 36 | 29.8% |
| Food and Beverage | $58,954 | 1,111 | 28.1% |
| Honoraria | $33,000 | 7 | 15.7% |
| Travel and Lodging | $28,571 | 70 | 13.6% |
| Consulting Fee | $18,695 | 9 | 8.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,000 | 4 | 3.8% |
| Entertainment | $275.85 | 3 | 0.1% |
| Education | $15.90 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avinger Inc. | $56,818 | 277 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $50,042 | 107 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $15,990 | 34 | $0 (2022) |
| Medtronic Vascular, Inc. | $14,665 | 194 | $0 (2020) |
| Cardiovascular Systems Inc. | $14,235 | 86 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $11,903 | 43 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $9,922 | 35 | $0 (2024) |
| Abbott Laboratories | $8,593 | 79 | $0 (2024) |
| Medtronic, Inc. | $6,015 | 104 | $0 (2024) |
| Penumbra, Inc. | $3,302 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,000 | 96 | Alnylam Pharmaceuticals Inc. ($5,911) |
| 2023 | $7,250 | 179 | Avinger Inc. ($1,630) |
| 2022 | $9,525 | 140 | Medtronic, Inc. ($4,151) |
| 2021 | $45,989 | 150 | Avinger Inc. ($36,518) |
| 2020 | $15,074 | 96 | Alnylam Pharmaceuticals Inc. ($3,675) |
| 2019 | $36,420 | 175 | Janssen Pharmaceuticals, Inc ($15,053) |
| 2018 | $31,795 | 194 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($12,657) |
| 2017 | $52,044 | 212 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($27,035) |
All Payment Transactions
1,242 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/15/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $67.26 | General |
| Category: Peripheral Intervention | ||||||
| 12/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Genetic Disease | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $135.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,380.00 | General |
| 11/26/2024 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $113.49 | General |
| Category: Aortic Stent Grafts | ||||||
| 11/20/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $170.62 | General |
| Category: Vascular | ||||||
| 11/13/2024 | Alnylam Pharmaceuticals Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| 11/12/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Genetic Disease | ||||||
| 11/07/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: Peripheral Intervention | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Abbott Laboratories | ABSOLUTE PRO (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Vascular | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Genetic Disease | ||||||
| 10/09/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $126.30 | General |
| Category: Genetic Disease | ||||||
| 10/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Genetic Disease | ||||||
| 10/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $136.29 | General |
| Category: Peripheral Intervention | ||||||
| 09/17/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Coronary | ||||||
| 09/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Genetic Disease | ||||||
| 08/22/2024 | Cook Medical LLC | ZILVER PTX (Device) | Food and Beverage | Cash or cash equivalent | $27.13 | General |
| Category: Peripheral Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 726 | 3,583 | $458,943 | $92,141 |
| 2022 | 21 | 627 | 941 | $1.4M | $340,526 |
| 2021 | 22 | 1,317 | 1,540 | $298,144 | $74,741 |
| 2020 | 28 | 1,461 | 1,635 | $463,631 | $105,910 |
Total Patients
4,131
Total Services
7,699
Medicare Billing
$613,319
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 377 | $152,494 | $31,363 | 20.6% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 13 | 18 | $56,199 | $12,320 | 21.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 66 | 66 | $47,404 | $8,841 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $35,903 | $7,095 | 19.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 20 | $31,360 | $6,297 | 20.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 29 | 30 | $24,365 | $4,927 | 20.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 20 | 40 | $13,800 | $3,632 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 47 | $14,989 | $3,101 | 20.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 18 | 72 | $30,240 | $2,221 | 7.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 12 | $7,706 | $2,087 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 15 | $4,925 | $1,938 | 39.3% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 12 | 15 | $7,652 | $1,778 | 23.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 15 | $3,384 | $1,329 | 39.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 24 | 24 | $7,008 | $1,070 | 15.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 17 | 29 | $4,862 | $1,040 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 93 | 101 | $5,835 | $981.10 | 16.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 20 | 20 | $5,160 | $919.02 | 17.8% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 17 | 72 | $2,571 | $549.09 | 21.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 15 | 2,200 | $1,387 | $254.45 | 18.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 20 | 22 | $733.60 | $200.20 | 27.3% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 15 | 229 | $860.44 | $164.02 | 19.1% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 14 | 23 | $58.50 | $23.17 | 39.6% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2023 | 15 | 71 | $45.90 | $8.72 | 19.0% |
| 37225 | Removal of plaque in arteries of leg | Office | 2022 | 23 | 27 | $454,965 | $140,957 | 31.0% |
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2022 | 16 | 21 | $350,212 | $126,251 | 36.0% |
About Dr. Dwight Dishmon, MD
Dr. Dwight Dishmon, MD is a Cardiovascular Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316904048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dwight Dishmon, MD has received a total of $210,097 in payments from pharmaceutical and medical device companies, with $12,000 received in 2024. These payments were reported across 1,242 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,585).
As a Medicare-enrolled provider, Dishmon has provided services to 4,131 Medicare beneficiaries, totaling 7,699 services with total Medicare billing of $613,319. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Memphis, TN
- Active Since 04/27/2006
- Last Updated 08/26/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1316904048
Products in Payments
- LifeVest (Device) $50,042
- PANTHERIS (Device) $44,296
- XARELTO (Drug) $15,882
- Peripheral Orbital Atherectomy System (Device) $11,713
- LUTONIX (Device) $8,648
- Resolute (Device) $7,854
- ONPATTRO (Drug) $4,074
- IN.PACT Admiral (Device) $3,831
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $3,595
- HAWKONE (Device) $3,112
- OptoWire (Device) $2,865
- Indigo System (Device) $2,588
- TurboHawk (Device) $2,182
- Diamondback Peripheral (Device) $1,526
- AURYON LASER SYSTEM 100-120 VAC (Device) $1,356
- HawkOne (Device) $1,209
- EKOSONIC (Device) $976.62
- Vascular Lithotripsy (Device) $841.19
- Supera peripheral stent system (Device) $840.37
- RESOLUTE ONYX (Device) $831.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Memphis
Dmitry Yaranov, Md, MD
Cardiovascular Disease — Payments: $600,772
Cardiovascular Disease $600,772
Steven Gubin, Md, MD
Cardiovascular Disease — Payments: $401,952
Cardiovascular Disease $401,952
Frank Mcgrew, Md, MD
Cardiovascular Disease — Payments: $231,282
Cardiovascular Disease $231,282
Claro Diaz, Md, MD
Cardiovascular Disease — Payments: $174,401
Cardiovascular Disease $174,401
Stevan Himmelstein, Md, MD
Cardiovascular Disease — Payments: $77,954
Cardiovascular Disease $77,954
Dr. Ikechukwu Ifedili, Md, MD
Cardiovascular Disease — Payments: $74,694
Cardiovascular Disease $74,694